Infectious Diseases in Children Respiratory Illnesses Vaccination Rates Vaccination Rare Diseases Injuries Infectious Diseases Hospital Care Genetic Disorders Cancer in Children
Published in Science Translational Medicine, the trial confirms larazotide’s gut-barrier mechanism can hasten MIS-C recovery prompting a new long COVID study